TABLE 3.
Information of DANCR in breast cancer from six research articles.
| Role of DANCR | DANCR expression in BC cell lines | Compared normal cell line | In vitro/in vivo validation | Tissue sample size | DANCR expression in tissues | References |
| Tumorigenesis | ↑: MCF7, T47D, MDA-MB-231, MDA-MB-468 |
Hs578Bst | Both | 63 (TNBC)/63 (ANT) | ↑: P = 0.009 | Sha et al., 2017 |
| Tumorigenesis | ↑: MCF7, T47D, BT549, MDA-MB-231, MDA-MB-468, MDA-MB-453 |
MCF10A | Both | 60 (TNBC)/10 (normal breast tissue); 60 (TNBC)/15 (Luminal A); 60 (TNBC)/15 (Luminal B) | ↑: P < 0.001; ↑: P < 0.05; ↑: P < 0.01 |
Tang et al., 2018 |
| Tumorigenesis | ↑: MCF7, MDA-MB-231 |
MCF10A | Both | 57 (TNBC)/57 (ANT) | ↑: P < 0.05 | Tao et al., 2019 |
| Tumorigenesis | ↑: MCF7, T47D, MDA-MB-231, MDA-MB-468 |
MCF10A | Both | 46 (BC)/46 (ANT) | ↑: P < 0.01 | Zhang K.J. et al., 2020 |
| Tumor suppression | ↓: MCF7, T47D, BT474, MDA-MB-436, MDA-MB-231, MDA-MB-231HM |
MCF10A | Both | 32 (BC)/32 (ANT) | ↓: P < 0.0001 | Li et al., 2017c |
| Tumor suppression | ↓: MCF7, T47D, MDA-MB-231HM ↑: BT549 |
MCF10A | Both | 25 (BC)/25 (ANT) | ↓ (P-value was not provided) | Li et al., 2017b |